-
DRL, Zydus recall drugs in US over manufacturing issues: USFDA
12 Oct 2025 19:17 GMT
… Report, US Food and Drug Administration (USFDA) stated … hepatitis B virus.
Pennington, New Jersey-based Zydus Pharmaceuticals … (USA) is recalling 912 and 600 bottles of Entecavir … lead to temporary or medically reversible health consequences, …
-
Dr Reddy's, Zydus Lifesciences recall medicines in US over quality issues
12 Oct 2025 12:51 GMT
… of Entecavir tablets, an antiviral medicine used mainly to treat chronic hepatitis B … first instance of Indian drug makers recalling medicines from the US market … .
In July this year, Sun Pharmaceutical Industries, headquartered in Mumbai, recalled …
-
Dr Reddy’s, Zydus Lifesciences recall medicines from US market over quality issues
12 Oct 2025 12:05 GMT
… , affecting muscle relaxant and hepatitis B drugs, are precautionary and classified … of Entecavir tablets, an antiviral medicine used mainly to treat chronic hepatitis B …
In July this year, Sun Pharmaceutical Industries, headquartered in Mumbai, recalled …
-
Dr Reddy’s, Zydus recall drugs in US over quality issues
12 Oct 2025 08:50 GMT
… bottles of Entecavir tablets—an antiviral drug used to treat chronic hepatitis B … product may cause temporary or medically reversible health effects, with minimal … the number of USFDA-approved pharmaceutical manufacturing facilities outside the United …
-
Dr Reddy's, Zydus recall drugs in US over manufacturing issues: USFDA
12 Oct 2025 08:31 GMT
… , US Food and Drug Administration (USFDA) stated … hepatitis B virus.
Pennington, New Jersey-based Zydus Pharmaceuticals … (USA) Inc is recalling 912 and 600 bottles of Entecavir … lead to temporary or medically reversible health consequences, …
-
Zydus recalls over 1500 bottles of Liver infection drug in US
10 Oct 2025 05:32 GMT
… Zydus Pharmaceuticals Inc. is undertaking recall of Hepatitis B virus (HBV) infection drug ‘Entecavir … to the US FDA latest enforcement report, the drugmaker has ordered … products may cause temporary or medically reversible adverse health consequences, and …
-
Hepatitis D Virus Classified as Carcinogenic: Implications
03 Oct 2025 08:48 GMT
… World Health Organization has classified hepatitis D virus (HDV) as … despite limited options.
Treatment Options
Randomized controlled trials have demonstrated antiviral efficacy … and nucleotide analogs, such as entecavir, tenofovir alafenamide fumarate, and …
-
Glenmark, Granules, Zydus and others recall medicines in US over quality issues: USFDA
28 Sep 2025 21:54 GMT
… Enforcement Report.
Glenmark Pharmaceuticals is recalling 13,824 … 3.
Similarly, Zydus Pharmaceuticals (USA) Inc, part … bottles of antiviral drug Entecavir tablets due to … medicine.
However, India has the highest number of USFDA-approved pharmaceutical …
-
Zydus recalls over 8700 bottles of Hepatitis drug in US
27 Sep 2025 21:14 GMT
… Pharmaceuticals Inc. is undertaking a voluntary recall of Hepatitis … B virus (HBV) infection drug ‘Entecavir’ due … US FDA latest enforcement report, the Ahmedabad-based drugmaker … may cause temporary or medically reversible adverse health …
-
Seroprevalence and Predictors of Hepatitis B and C Virus Infections Among Patients with Chronic Liver Diseases in Dodoma Region, Tanzania: A Cross-Sectional Study
23 Sep 2025 08:49 GMT
… the researchers and two general medical doctors who were first trained regarding … behaviors such as intravenous illicit drugs, tattooing, ear piercing among … markers in hepatitis B virus-associated cirrhosis: 2years of entecavir treatment. J Gastroenterol …
About
© 1995-2025